Changchun High & New Technology Industries Group Inc (000661) - Total Assets
Based on the latest financial reports, Changchun High & New Technology Industries Group Inc (000661) holds total assets worth CN¥30.77 Billion CNY (≈ $4.50 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Changchun High & New Technology Industries Group Inc - Total Assets Trend (1993–2025)
This chart illustrates how Changchun High & New Technology Industries Group Inc's total assets have evolved over time, based on quarterly financial data. Also see Changchun High & New Technology Industri market cap and net worth for the company's overall valuation and market capitalisation.
Changchun High & New Technology Industries Group Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Changchun High & New Technology Industries Group Inc's total assets of CN¥30.77 Billion consist of 45.9% current assets and 54.1% non-current assets. Review Changchun High & New Technology Industri (000661) total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 7.2% |
| Accounts Receivable | CN¥2.03 Billion | 6.8% |
| Inventory | CN¥5.83 Billion | 19.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥3.69 Billion | 12.3% |
| Goodwill | CN¥76.61 Million | 0.3% |
Asset Composition Trend (1993–2025)
This chart illustrates how Changchun High & New Technology Industries Group Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See current stock price of Changchun High & New Technology Industri for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Changchun High & New Technology Industries Group Inc's current assets represent 45.9% of total assets in 2025, a decrease from 58.1% in 1993.
- Cash Position: Cash and equivalents constituted 7.2% of total assets in 2025, up from 0.0% in 1993.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 12.0% of total assets, an increase from 4.0% in 1993.
- Asset Diversification: The largest asset category is inventory at 19.4% of total assets.
Changchun High & New Technology Industries Group Inc Competitors by Total Assets
Key competitors of Changchun High & New Technology Industries Group Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Yunnan Baiyao Group Co Ltd
SHE:000538
|
China | CN¥53.34 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Harbin Gloria Pharmaceuticals
SHE:002437
|
China | CN¥3.14 Billion |
|
Jiuzhitang Co Ltd
SHE:000989
|
China | CN¥5.73 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
Changchun High & New Technology Industries Group Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.52 | 4.32 | 4.33 |
| Quick Ratio | 2.10 | 2.96 | 3.18 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥10.27 Billion | CN¥12.28 Billion | CN¥10.33 Billion |
Changchun High & New Technology Industries Group Inc - Advanced Valuation Insights
This section examines the relationship between Changchun High & New Technology Industries Group Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.59 |
| Latest Market Cap to Assets Ratio | 0.14 |
| Asset Growth Rate (YoY) | -3.1% |
| Total Assets | CN¥30.08 Billion |
| Market Capitalization | $4.27 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Changchun High & New Technology Industries Group Inc's assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Changchun High & New Technology Industries Group Inc's assets decreased by 3.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Changchun High & New Technology Industries Group Inc (1993–2025)
The table below shows the annual total assets of Changchun High & New Technology Industries Group Inc from 1993 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥30.08 Billion ≈ $4.40 Billion |
-3.13% |
| 2024-12-31 | CN¥31.05 Billion ≈ $4.54 Billion |
+1.00% |
| 2023-12-31 | CN¥30.74 Billion ≈ $4.50 Billion |
+18.12% |
| 2022-12-31 | CN¥26.03 Billion ≈ $3.81 Billion |
+15.60% |
| 2021-12-31 | CN¥22.52 Billion ≈ $3.29 Billion |
+33.19% |
| 2020-12-31 | CN¥16.91 Billion ≈ $2.47 Billion |
+32.89% |
| 2019-12-31 | CN¥12.72 Billion ≈ $1.86 Billion |
+34.87% |
| 2018-12-31 | CN¥9.43 Billion ≈ $1.38 Billion |
+28.30% |
| 2017-12-31 | CN¥7.35 Billion ≈ $1.08 Billion |
+18.50% |
| 2016-12-31 | CN¥6.20 Billion ≈ $907.77 Million |
+62.59% |
| 2015-12-31 | CN¥3.82 Billion ≈ $558.33 Million |
+21.19% |
| 2014-12-31 | CN¥3.15 Billion ≈ $460.71 Million |
+12.06% |
| 2013-12-31 | CN¥2.81 Billion ≈ $411.12 Million |
+21.39% |
| 2012-12-31 | CN¥2.31 Billion ≈ $338.67 Million |
+12.43% |
| 2011-12-31 | CN¥2.06 Billion ≈ $301.23 Million |
+16.85% |
| 2010-12-31 | CN¥1.76 Billion ≈ $257.78 Million |
+13.59% |
| 2009-12-31 | CN¥1.55 Billion ≈ $226.93 Million |
+0.21% |
| 2008-12-31 | CN¥1.55 Billion ≈ $226.45 Million |
+2.36% |
| 2007-12-31 | CN¥1.51 Billion ≈ $221.22 Million |
+3.61% |
| 2006-12-31 | CN¥1.46 Billion ≈ $213.50 Million |
+3.20% |
| 2005-12-31 | CN¥1.41 Billion ≈ $206.88 Million |
+1.42% |
| 2004-12-31 | CN¥1.39 Billion ≈ $203.99 Million |
-10.13% |
| 2003-12-31 | CN¥1.55 Billion ≈ $226.98 Million |
+27.00% |
| 2002-12-31 | CN¥1.22 Billion ≈ $178.72 Million |
-3.06% |
| 2001-12-31 | CN¥1.26 Billion ≈ $184.36 Million |
+9.25% |
| 2000-12-31 | CN¥1.15 Billion ≈ $168.76 Million |
-14.31% |
| 1999-12-31 | CN¥1.35 Billion ≈ $196.95 Million |
+3.41% |
| 1998-12-31 | CN¥1.30 Billion ≈ $190.46 Million |
+48.42% |
| 1997-12-31 | CN¥876.96 Million ≈ $128.33 Million |
+18.93% |
| 1996-12-31 | CN¥737.35 Million ≈ $107.90 Million |
+43.35% |
| 1995-12-31 | CN¥514.37 Million ≈ $75.27 Million |
+43.97% |
| 1994-12-31 | CN¥357.28 Million ≈ $52.28 Million |
+15.61% |
| 1993-12-31 | CN¥309.04 Million ≈ $45.22 Million |
-- |
About Changchun High & New Technology Industries Group Inc
Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers recombinant human growth hormone injection; recombinant human follicle stimulating hormone for injection; herpes zoster vaccines; live attenuated varicella vaccine; freeze-dried nasa… Read more